17
Jun 2016
NHS to fund pioneering skin cancer drug
The combination therapy drug unleashes the immune system and in trials was shown to shrink the most aggressive type of skin cancer in 69% of patients. The drug, which will be paid for by the NHS in England and is likely to be approved throughout the UK, is giving “new hope” to cancer patients. Immunotherapy…

